Mark A Smith Selected Research

Mark A Smith Research Topics

Disease

206	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 01/2002
46	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2012 - 01/2002
29	Amyloid Plaque 05/2014 - 01/2002
24	Parkinson Disease (Parkinson's Disease) 10/2012 - 03/2002
19	Dementia (Dementias) 01/2018 - 01/2002
16	Substance-Related Disorders (Drug Abuse) 01/2022 - 11/2008
15	Cognitive Dysfunction 04/2014 - 05/2004
13	Neuroblastoma 01/2012 - 03/2003
10	Mitochondrial Diseases (Mitochondrial Disease) 06/2013 - 05/2002
9	Inflammation (Inflammations) 04/2015 - 10/2005
8	Schizophrenia (Dementia Praecox) 01/2022 - 08/2005
8	Disease Progression 01/2010 - 10/2004
8	Hypoxia (Hypoxemia) 01/2010 - 01/2003
7	Body Weight (Weight, Body) 10/2018 - 08/2003
7	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 10/2012 - 03/2002
7	Prion Diseases (Transmissible Spongiform Encephalopathies) 04/2011 - 04/2002
6	Obesity 05/2016 - 08/2003
5	Neoplasms (Cancer) 11/2020 - 07/2003
5	Infections 05/2013 - 04/2005
5	Tauopathies 07/2011 - 03/2003
4	Opioid-Related Disorders (Opiate Addiction) 04/2022 - 12/2017
4	Psychotic Disorders (Schizoaffective Disorder) 12/2011 - 08/2005
3	Major Depressive Disorder (Major Depressive Disorders) 01/2022 - 08/2013
3	Insulin Resistance 10/2018 - 03/2011
3	Cocaine-Related Disorders (Cocaine Addiction) 02/2012 - 04/2004
3	Diabetes Mellitus 01/2012 - 02/2005
3	Hyperglycemia 01/2012 - 03/2002
3	Iron Overload 08/2011 - 09/2005
3	Lewy Body Disease (Lewy Body Dementia) 01/2011 - 07/2009
3	Pathologic Processes 02/2010 - 09/2002

Drug/Important Bio-Agent (IBA)

55	Amyloid beta-PeptidesIBA 09/2010 - 01/2002
39	Proteins (Proteins, Gene)FDA Link 01/2014 - 01/2002
30	Amyloid (Amyloid Fibrils)IBA 05/2014 - 07/2002
25	MetalsIBA 02/2012 - 01/2002
23	IronIBA 08/2011 - 01/2002
21	Pharmaceutical PreparationsIBA 01/2021 - 09/2002
19	AntioxidantsIBA 07/2010 - 02/2002
17	Estrogens (Estrogen)FDA Link 04/2022 - 07/2003
13	GonadotropinsIBA 01/2018 - 11/2002
13	EnzymesIBA 01/2012 - 03/2003
13	Free RadicalsIBA 01/2010 - 04/2002
11	Luteinizing Hormone (Lutropin)FDA LinkGeneric 07/2014 - 11/2002
11	Nucleic AcidsIBA 03/2010 - 03/2002
10	Glucose (Dextrose)FDA LinkGeneric 10/2018 - 10/2005
9	LeptinIBA 10/2018 - 08/2007
9	RNA (Ribonucleic Acid)IBA 10/2012 - 03/2002
9	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2012 - 01/2002
9	CopperIBA 08/2011 - 01/2002
8	Hormones (Hormone)IBA 04/2014 - 01/2004
8	Phosphotransferases (Kinase)IBA 03/2011 - 08/2006
7	Heme Oxygenase-1IBA 01/2010 - 03/2003
7	Amyloid beta-Protein Precursor (Amyloid Protein Precursor)IBA 01/2010 - 09/2002
7	Chelating AgentsIBA 01/2010 - 03/2003
6	SteroidsIBA 01/2018 - 01/2004
6	Peptides (Polypeptides)IBA 01/2013 - 04/2002
6	Oxidants (Oxidizing Agents)IBA 12/2009 - 02/2002
6	Heme (Haem)IBA 09/2009 - 03/2003
5	AntibodiesIBA 04/2015 - 03/2005
5	CholesterolIBA 06/2011 - 07/2002
5	tau Proteins (tau Protein)IBA 04/2008 - 03/2003
4	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2020 - 09/2005
4	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2018 - 04/2005
4	Cocaine (Cocaine HCl)IBA 06/2016 - 11/2008
4	Neuroprotective AgentsIBA 04/2014 - 11/2007
4	DNA (Deoxyribonucleic Acid)IBA 04/2012 - 03/2002
4	8-hydroxyguanosineIBA 03/2012 - 11/2002
4	Advanced Glycation End ProductsIBA 01/2012 - 05/2002
4	Insulin (Novolin)FDA Link 04/2011 - 02/2005
4	HomocysteineIBA 01/2010 - 06/2004
4	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2010 - 02/2008
4	LipidsIBA 01/2010 - 01/2005
4	Glycogen Synthase Kinase 3 betaIBA 05/2009 - 06/2004
4	Mitogen-Activated Protein KinasesIBA 03/2009 - 09/2002
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2006 - 03/2002
3	Antidepressive Agents (Antidepressants)IBA 01/2022 - 08/2013
3	metabotropic glutamate receptor 2IBA 01/2022 - 04/2004
3	Glutamate Receptors (Glutamate Receptor)IBA 01/2021 - 09/2002
3	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 10/2018 - 08/2007
3	Leuprolide (Lupron)FDA LinkGeneric 01/2018 - 04/2006
3	Glutamic Acid (Glutamate)FDA Link 04/2016 - 09/2002
3	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2015 - 09/2005
3	Mitochondrial DNA (mtDNA)IBA 06/2013 - 03/2003
3	Neurotransmitter Agents (Neurotransmitter)IBA 09/2012 - 10/2005
3	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 05/2012 - 07/2003
3	NucleosidesIBA 03/2012 - 11/2002
3	ZincIBA 08/2011 - 11/2007
3	Prion ProteinsIBA 04/2011 - 04/2005
3	Leucine (L-Leucine)FDA Link 01/2011 - 11/2006
3	Biomarkers (Surrogate Marker)IBA 02/2010 - 11/2006
3	Amyloidogenic ProteinsIBA 02/2010 - 01/2004
3	Memantine (Namenda)FDA Link 02/2010 - 09/2005
3	IonsIBA 01/2010 - 07/2002
3	PresenilinsIBA 01/2010 - 10/2005
3	Presenilin-1IBA 01/2010 - 06/2002
3	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 09/2009 - 03/2003

Therapy/Procedure

27	Therapeutics 01/2022 - 04/2002
5	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2018 - 08/2004
5	Self Administration (Administration, Self) 06/2016 - 12/2011
3	Drug Therapy (Chemotherapy) 04/2022 - 04/2004
3	Estrogen Replacement Therapy 07/2014 - 03/2003